Caffeine intake interacts with Asian gene variants in Parkinson's disease, may lower risk

bySingHealthComparing ORs for PD stratified by genetic carrier status at LRRK2 risk loci and caffeine consumption. a. Comparing ORs for PD stratified by genetic carrier status at S1647T loci and

Updated on: April 22,2024

Caffeine intake interacts with Asian gene variants in Parkinson's disease, may lower risk

bySingHealthComparing ORs for PD stratified by genetic carrier status at LRRK2 risk loci and caffeine consumption. a. Comparing ORs for PD stratified by genetic carrier status at S1647T loci and

Updated on:April 22,2024

Insights on the link between chronic stress and Alzheimer's disease

by WileyCredit: Pixabay/CC0 Public DomainChronic psychosocial stress—which involves a pathway called the hypothalamic-pituitary-adrenal axis (HPA axis)—may contribute to the development of Alzhei

Updated on: June 05,2024

Insights on the link between chronic stress and Alzheimer's disease

by WileyCredit: Pixabay/CC0 Public DomainChronic psychosocial stress—which involves a pathway called the hypothalamic-pituitary-adrenal axis (HPA axis)—may contribute to the development of Alzhei

Updated on:June 05,2024

New research suggests why males and females respond differently to social stress

by Alex Russell,UC DavisCredit: CC0 Public DomainWomen are nearly twice as likely as men to be diagnosed with an anxiety disorder, but among boys and girls the likelihood is the same. New Univer

Updated on: January 12,2024

New research suggests why males and females respond differently to social stress

by Alex Russell,UC DavisCredit: CC0 Public DomainWomen are nearly twice as likely as men to be diagnosed with an anxiety disorder, but among boys and girls the likelihood is the same. New Univer

Updated on:January 12,2024

Individuals with high Alzheimer's risk may use attention to process, rather than suppress, distracting stimuli

by California Institute of TechnologyPractice makes imperfect: stronger implicit interference with practice in individuals at high risk of developing Alzheimer’s disease. An example trial sequenc

Updated on: February 24,2024

Individuals with high Alzheimer's risk may use attention to process, rather than suppress, distracting stimuli

by California Institute of TechnologyPractice makes imperfect: stronger implicit interference with practice in individuals at high risk of developing Alzheimer’s disease. An example trial sequenc

Updated on:February 24,2024

New insights into the development of Parkinson's disease in the brain might open the doors to new therapies

byTokyo Medical and Dental UniversityIn healthy condition, CHCHD2WT localizes in mitochondria. In pathogenic condition, mutant CHCHD2T61I mislocalizes to the cytosol and recruits Casein kinase 1

Updated on: March 14,2024

New insights into the development of Parkinson's disease in the brain might open the doors to new therapies

byTokyo Medical and Dental UniversityIn healthy condition, CHCHD2WT localizes in mitochondria. In pathogenic condition, mutant CHCHD2T61I mislocalizes to the cytosol and recruits Casein kinase 1

Updated on:March 14,2024

Scientists uncover the role of dopamine in mediating short-term and long-term memory dynamics

by Tejasri Gururaj , Medical XpressNeural activity gives information about how fruit flies respond to various sensory stimuli, revealing insights into how they process and encode these experiences int

Updated on: September 09,2024

Scientists uncover the role of dopamine in mediating short-term and long-term memory dynamics

by Tejasri Gururaj , Medical XpressNeural activity gives information about how fruit flies respond to various sensory stimuli, revealing insights into how they process and encode these experiences int

Updated on:September 09,2024

Study questions benefit of new Alzheimer's drug

by Lauren Baggett,University of GeorgiaCredit: CC0 Public DomainLast summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. Bu

Updated on: April 23,2024

Study questions benefit of new Alzheimer's drug

by Lauren Baggett,University of GeorgiaCredit: CC0 Public DomainLast summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer's. Bu

Updated on:April 23,2024

How decision-making mechanisms go awry in OCD brains

by Maddie Massy-Westropp,University of New South WalesExperienced value—devaluation test results. Credit:Biological Psychiatry Global Open Science(2022). DOI: 10.1016/j.bpsgos.2022.1

Updated on: January 12,2024

How decision-making mechanisms go awry in OCD brains

by Maddie Massy-Westropp,University of New South WalesExperienced value—devaluation test results. Credit:Biological Psychiatry Global Open Science(2022). DOI: 10.1016/j.bpsgos.2022.1

Updated on:January 12,2024

Identifying typical patterns in the progression towards Alzheimer's disease

by University of MontrealHow the brain progresses from mild cognitive impairment (MCI) to Alzheimer's-type dementia has been an enigma for the scientific community. However, a recent study by

Updated on: February 26,2024

Identifying typical patterns in the progression towards Alzheimer's disease

by University of MontrealHow the brain progresses from mild cognitive impairment (MCI) to Alzheimer's-type dementia has been an enigma for the scientific community. However, a recent study by

Updated on:February 26,2024

Anxiety symptoms may be early indicator of Alzheimer's disease

by Monash UniversityCredit: CC0 Public DomainNew research suggests that anxiety symptoms in late-middle-aged adults may be an indicator of the earliest stage of Alzheimer's disease.Thes

Updated on: June 24,2024

Anxiety symptoms may be early indicator of Alzheimer's disease

by Monash UniversityCredit: CC0 Public DomainNew research suggests that anxiety symptoms in late-middle-aged adults may be an indicator of the earliest stage of Alzheimer's disease.Thes

Updated on:June 24,2024

ClearTau: A new tool for studying neurodegenerative diseases

byEcole Polytechnique Federale de LausanneA ClearTau platform that reconstructs pathology-resembling Tau fibrils in vitro for research into Tau aggregation processes and the development of Tau f

Updated on: January 21,2024

ClearTau: A new tool for studying neurodegenerative diseases

byEcole Polytechnique Federale de LausanneA ClearTau platform that reconstructs pathology-resembling Tau fibrils in vitro for research into Tau aggregation processes and the development of Tau f

Updated on:January 21,2024

Senescent glial cell: A key player in lipid accumulation and brain aging

Updated on: October 21,2024

Senescent glial cell: A key player in lipid accumulation and brain aging

Updated on:October 21,2024